University Medical Center Hamburg-Eppendorf at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
University Medical Center Hamburg-Eppendorf takes part in 6 sessions at ESMO 2026 in Madrid. Its program centres on metastatic breast cancer, including personalised maintenance in HER2-positive disease, and on antibody-drug conjugates in bladder cancer. Other sessions cover melanoma and other skin tumours and whether clinical practice guidelines improve survival and quality of life.
| Organization | ESMO 2026 Attendance |
|---|---|
University Medical Center Hamburg-Eppendorf Hamburg, Germany | |
Public university hospital and medical faculty of the University of Hamburg in Hamburg, Germany. | Abstract Fri Oct 23 13:40–13:45 Abstract Sat Oct 24 10:25–10:35 Satellite Sat Oct 24 13:55–14:20 Charting the Future of Bladder Cancer Through Novel ADC Developments Genitourinary cancers Chair Sun Oct 25 10:15–11:45 Rapid oral: Melanoma and other skin tumours Melanoma & skin cancers Abstract Sun Oct 25 11:19–11:29 Invited Discussant LBA61 and 2076RO Melanoma & skin cancers Satellite Sun Oct 25 18:38–19:33 Satellite Sun Oct 25 19:33–19:48 Satellite Sun Oct 25 19:48–19:58 Ask the Expert: Panel Discussion and Audience Q&A Breast cancer Talk Mon Oct 26 15:05–15:25 |
Instantly find 20 buyers from University Medical Center Hamburg-Eppendorf
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction